P30 DK089507/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2010	1
2011	6
2012	21
2013	24
2014	36
2015	51
2016	44
2017	58
2018	56
2019	54
2020	53
2021	58
2022	51
2023	56
2024	22

1

Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice.

Hale M, Takehara KK, Thouvenel CD, Moustafa DA, Repele A, Fontana MF, Netland J, McNamara S, Gibson RL, Goldberg JB, Rawlings DJ, Pepper M. Hale M, et al. bioRxiv [Preprint]. 2024 Apr 12:2024.04.08.588618. doi: 10.1101/2024.04.08.588618. bioRxiv. 2024. PMID: 38645147 Free PMC article. Preprint.

2

"We'll deal with it as it comes": A Qualitative Analysis of Romantic Partners' Dyadic Coping in Cystic Fibrosis.

Lau N, Ramos KJ, Aitken ML, Goss CH, Barton KS, Kross EK, Engelberg RA. Lau N, et al. J Soc Pers Relat. 2024 Apr;41(4):689-705. doi: 10.1177/02654075231190617. Epub 2023 Jul 21. J Soc Pers Relat. 2024. PMID: 38638205 Free PMC article.

3

Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesis.

Stonebraker JR, Pace RG, Gallins PJ, Dang H, Aksit MA, Faino AV, Gordon WW, MacParland S, Bamshad MJ, Gibson RL, Cutting GR, Durie PR, Wright FA, Zhou YH, Blackman SM, O'Neal WK, Ling SC, Knowles MR. Stonebraker JR, et al. Hepatology. 2024 Mar 27. doi: 10.1097/HEP.0000000000000863. Online ahead of print. Hepatology. 2024. PMID: 38536042

4

Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor.

Duong JT, Pope CE, Hayden HS, Miller C, Salipante SJ, Rowe SM, Solomon GM, Nichols D, Hoffman LR, Narkewicz MR, Green N. Duong JT, et al. J Cyst Fibros. 2024 Mar 6:S1569-1993(24)00029-8. doi: 10.1016/j.jcf.2024.02.015. Online ahead of print. J Cyst Fibros. 2024. PMID: 38448281 Free article.

5

Massively parallel mutant selection identifies genetic determinants of Pseudomonas aeruginosa colonization of Drosophila melanogaster.

Miles J, Lozano GL, Rajendhran J, Stabb EV, Handelsman J, Broderick NA. Miles J, et al. mSystems. 2024 Mar 19;9(3):e0131723. doi: 10.1128/msystems.01317-23. Epub 2024 Feb 21. mSystems. 2024. PMID: 38380971 Free PMC article.

6

Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis.

Zemanick ET, Emerman I, McCreary M, Mayer-Hamblett N, Warden MN, Odem-Davis K, VanDevanter DR, Ren CL, Young J, Konstan MW; CHEC-SC Study Group. Zemanick ET, et al. J Cyst Fibros. 2024 Feb 14:S1569-1993(24)00015-8. doi: 10.1016/j.jcf.2024.02.001. Online ahead of print. J Cyst Fibros. 2024. PMID: 38360461

7

MEK1/2 inhibition decreases pro-inflammatory responses in macrophages from people with cystic fibrosis and mitigates severity of illness in experimental murine methicillin-resistant Staphylococcus aureus infection.

De M, Serpa G, Zuiker E, Hisert KB, Liles WC, Manicone AM, Hemann EA, Long ME. De M, et al. Front Cell Infect Microbiol. 2024 Jan 30;14:1275940. doi: 10.3389/fcimb.2024.1275940. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38352056 Free PMC article.

8

Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries.

Calthorpe R, Rosenfeld M, Goss CH, Green N, Derleth M, Carr SB, Smyth A, Stewart I. Calthorpe R, et al. J Cyst Fibros. 2024 Feb 10:S1569-1993(24)00012-2. doi: 10.1016/j.jcf.2024.01.011. Online ahead of print. J Cyst Fibros. 2024. PMID: 38342635 Free article.

9

Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.

Reasoner SA, Bernard R, Waalkes A, Penewit K, Lewis J, Sokolow AG, Brown RF, Edwards KM, Salipante SJ, Hadjifrangiskou M, Nicholson MR. Reasoner SA, et al. mBio. 2024 Feb 14;15(2):e0193523. doi: 10.1128/mbio.01935-23. Epub 2024 Jan 26. mBio. 2024. PMID: 38275294 Free PMC article.

10

Qualitative Analysis of Perspectives on Lung Transplant among People with Cystic Fibrosis.

Milinic T, Hobler MR, Bartlett LE, Gill E, Burdis N, Engelberg RA, Curtis JR, Hartzler AL, Aitken ML, Kapnadak SG, Goss CH, Smith PJ, Ramos KJ. Milinic T, et al. Ann Am Thorac Soc. 2024 Jan 23. doi: 10.1513/AnnalsATS.202307-625OC. Online ahead of print. Ann Am Thorac Soc. 2024. PMID: 38259137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

517 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

517 results

Results by year